A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Erlotinib Impurity 11 | CAS 179688-26-7 - Request Quote

Picture of Erlotinib Impurity 11

Erlotinib Impurity 11

SZ CAT No:SZ-E018027
CAS No
179688-26-7
Mol.F.
C15H21NO8
Mol.Wt.
343.3
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Erlotinib Impurity 11 is chemically Ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate. Erlotinib Impurity 11 is supplied with detailed characterization data compliant with regulatory guideline. Erlotinib Impurity 11 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erlotinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 179688-26-7

Purchase 179688-26-7

Order 179688-26-7

Enquire 179688-26-7

price of 179688-26-7

179688-26-7 Supplier

179688-26-7 Manufacturer

179688-26-7 Exporter

buy high quality Erlotinib Impurity 11

Purchase Erlotinib Impurity 11

Erlotinib Impurity 11 suppliers

Erlotinib Impurity 11 manufacturers

Erlotinib Impurity 11 price

Order Erlotinib Impurity 11

Enquire Erlotinib Impurity 11

Erlotinib Impurity 11 cost

Erlotinib Impurity 11 Supplier

Erlotinib Impurity 11 Distributor

Erlotinib Impurity 11 for Method Validation

Erlotinib Reference Standard

Erlotinib Impurity 11 for ANDA Filing

Erlotinib Impurity 11 for Forced Degradation Studies

Erlotinib Impurity 11 Identification Standards

Erlotinib Impurity 11 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,